Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus
Research output: Contribution to journal › Review › Research › peer-review
Standard
Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases : an International Organization for Study of Inflammatory Bowel Diseases consensus. / Ananthakrishnan, A.; Kaplan, G.; Bernstein, C.; Burke, Kristin E.; Lochhead, Paul J.; Sasson, Alexa N.; Agrawal, Manasi; Tiong, Jimmy Ho Tuan; Steinberg, Joshua; Kruis, W.; Steinwurz, Flavio; Ahuja, V.; Ng, Siew C.; Rubin, David T.; Colombel, Jean Frederic; Gearry, Richard; Abreu, M.; Ahuja, V.; Allez, M.; Ananthakrishnan, A.; Bemelman, W.; Bernstein, C.; Braun, J.; Chowers, Y.; Colombel, J. F.; Danese, S.; D'Haens, G.; D'Hoore, A.; Dignass, A.; Dotan, I.; Dubinsky, M.; Ekbom, A.; Fleshner, P.; Gasche, C.; Gassull, M. A.; Ghosh, S.; Gibson, P.; Griffiths, A.; Halfvarson, J.; Hanauer, S.; Harpaz, N.; Hart, A.; Hibi, T.; Kamm, M.; Kaplan, G.; Kaser, A.; Korelitz, B.; Kotze, P.; Koutroubakis, I.; Munkholm, P.; International Organization for Study of Inflammatory Bowel Diseases.
In: The Lancet Gastroenterology and Hepatology, Vol. 7, No. 7, 2022, p. 666-678.Research output: Contribution to journal › Review › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases
T2 - an International Organization for Study of Inflammatory Bowel Diseases consensus
AU - Ananthakrishnan, A.
AU - Kaplan, G.
AU - Bernstein, C.
AU - Burke, Kristin E.
AU - Lochhead, Paul J.
AU - Sasson, Alexa N.
AU - Agrawal, Manasi
AU - Tiong, Jimmy Ho Tuan
AU - Steinberg, Joshua
AU - Kruis, W.
AU - Steinwurz, Flavio
AU - Ahuja, V.
AU - Ng, Siew C.
AU - Rubin, David T.
AU - Colombel, Jean Frederic
AU - Gearry, Richard
AU - Abreu, M.
AU - Ahuja, V.
AU - Allez, M.
AU - Ananthakrishnan, A.
AU - Bemelman, W.
AU - Bernstein, C.
AU - Braun, J.
AU - Chowers, Y.
AU - Colombel, J. F.
AU - Danese, S.
AU - D'Haens, G.
AU - D'Hoore, A.
AU - Dignass, A.
AU - Dotan, I.
AU - Dubinsky, M.
AU - Ekbom, A.
AU - Fleshner, P.
AU - Gasche, C.
AU - Gassull, M. A.
AU - Ghosh, S.
AU - Gibson, P.
AU - Griffiths, A.
AU - Halfvarson, J.
AU - Hanauer, S.
AU - Harpaz, N.
AU - Hart, A.
AU - Hibi, T.
AU - Kamm, M.
AU - Kaplan, G.
AU - Kaser, A.
AU - Korelitz, B.
AU - Kotze, P.
AU - Koutroubakis, I.
AU - Munkholm, P.
AU - International Organization for Study of Inflammatory Bowel Diseases
N1 - Publisher Copyright: © 2022 Elsevier Ltd
PY - 2022
Y1 - 2022
N2 - Environmental and lifestyle factors play an important role in the natural history of Crohn's disease and ulcerative colitis. A group of international experts from the International Organization for the Study of Inflammatory Bowel Diseases voted on a series of consensus statements to inform the management of inflammatory bowel disease (IBD). The recommendations include avoiding traditional cigarette smoking in patients with Crohn's disease or ulcerative colitis, screening for symptoms of depression, anxiety, and psychosocial stressors at diagnosis and during flares (with referral to mental health professionals when appropriate), and encouraging regular physical activity as tolerated. Patients using dietary approaches for treatment of their IBD should be encouraged to adopt diets that are best supported by evidence and involve monitoring for the objective resolution of inflammation. We recommend formal assessment for obesity and nutritional deficiencies, and patients should be encouraged to maintain a normal body-mass index. A shared decision-making approach to contraception should include the consideration of IBD-related factors, and risk factors for venous thromboembolism. Long-term or frequent use of high-dose non-steroidal anti-inflammatory drugs should be avoided. For primary prevention of disease in the offspring of patients with IBD, we recommend avoiding passive exposure to tobacco, using antibiotics judiciously, and considering breastfeeding when able.
AB - Environmental and lifestyle factors play an important role in the natural history of Crohn's disease and ulcerative colitis. A group of international experts from the International Organization for the Study of Inflammatory Bowel Diseases voted on a series of consensus statements to inform the management of inflammatory bowel disease (IBD). The recommendations include avoiding traditional cigarette smoking in patients with Crohn's disease or ulcerative colitis, screening for symptoms of depression, anxiety, and psychosocial stressors at diagnosis and during flares (with referral to mental health professionals when appropriate), and encouraging regular physical activity as tolerated. Patients using dietary approaches for treatment of their IBD should be encouraged to adopt diets that are best supported by evidence and involve monitoring for the objective resolution of inflammation. We recommend formal assessment for obesity and nutritional deficiencies, and patients should be encouraged to maintain a normal body-mass index. A shared decision-making approach to contraception should include the consideration of IBD-related factors, and risk factors for venous thromboembolism. Long-term or frequent use of high-dose non-steroidal anti-inflammatory drugs should be avoided. For primary prevention of disease in the offspring of patients with IBD, we recommend avoiding passive exposure to tobacco, using antibiotics judiciously, and considering breastfeeding when able.
U2 - 10.1016/S2468-1253(22)00021-8
DO - 10.1016/S2468-1253(22)00021-8
M3 - Review
C2 - 35487235
AN - SCOPUS:85131835044
VL - 7
SP - 666
EP - 678
JO - The Lancet Gastroenterology and Hepatology
JF - The Lancet Gastroenterology and Hepatology
SN - 2468-1253
IS - 7
ER -
ID: 331361243